Q2 Missed Guidance by 60%, PAT Fell 17% — Order Book Surge Is the Only Win
EMS promised 30-35% revenue growth; delivered 12.4% and saw profit slide 16.8% lower. The ₹3,152 Crore order book is real and visible for 2+ years, but ₹450 Crore in stuck government receivables and near-term execution risk make the case hold, not buy.
30–35% YoY
set on FY27 Q1 call
12.4% YoY
₹193.9 Cr
60% below target
guidance gap
-16.8% YoY
₹23.4 Cr
On the face of the numbers, EMS Limited cleared its top-line bar: Q2 consolidated revenue of ₹193.9 Crore exceeded the ₹160.89 Crore in standalone revenue management cited on the call. But the market's read of that result is not on the absolute, it is on the miss. Management had guided for 30–35% year-on-year revenue growth in Q2 (set during the Q1 earnings call, in the context of a full-year FY27 target of ₹900–950 Crore implying 50% YoY growth). This quarter delivered 12.4% YoY growth — a 60% shortfall against the low end of the range. Worse, consolidated profit fell 16.8% year-on-year to ₹23.4 Crore, directly contradicting management's on-call claim of 50% EBITDA and PAT growth. That 67-percentage-point divergence (claimed +50%, actual −17%) is the core tension of this quarter.
Claims vs. the Reality: The Grading
50% EBITDA and PAT growth in Q2
ContradictedConsolidated PAT −16.8% YoY (₹23.4 Cr). EBITDA margin compressed from 20.2% (Q1) to 18.5% (Q2).
Order book of ₹3,152 Cr; ₹900 Cr added this quarter
SupportedSupported by state-wise breakdown: ₹2,619 Cr CAPEX, ₹533 Cr O&M work. Aligns with CEO commentary on Jal board tender wins.
Receivables issue in Uttarakhand being resolved; fund flow normalizing
Partial₹450+ Cr trade receivables still outstanding; payment delays 6+ months. Government portal corrected recently, but inflow not yet visible.
Can execute 40% of order book per year at typical 2–2.5 year project cycles
OverstatedIf valid: ₹3,152 Cr ÷ 2.5 years = ₹1,261 Cr annual capacity. Q2 delivered ₹193.9 Cr (15% of claimed capacity). Execution risk remains unproven.
The dividend of this table: management's near-term credibility has taken a hit. Promised 30–35% growth, delivered 12.4%. Claimed 50% profit expansion, saw profit contract 17%. The order book and receivables narratives are intact, but they are forward-looking; Q2 itself was a miss, and the miss was real.
The Offset: ₹3,152 Crore Order Book
What prevents this quarter from being a simple downgrade is the order book. EMS added ₹900 Crore in new CAPEX and O&M work in Q2 alone, pushing the total visible order book to ₹3,152 Crore — equivalent to 1.5× the company's trailing annual revenue. For a civil engineering firm operating in water supply and sewage treatment (the bedrock of India's 15-lakh-crore water infrastructure opportunity), that visibility is material. The order book is real, granular by state and project type, and anchored to tender wins from Delhi Jal Board, PHED Rajasthan, UP Jal Nigam, and Central government Namami Ganga and Amrit projects. But the order book's size is not the same as the order book's execution. Management's assumption that 40% of the outstanding order book can convert to revenue annually — yielding ₹1,261 Crore per year at the current ₹3,152 Crore stock — is an aspiration, not a track record. Q2 delivered ₹193.9 Crore against a ₹3,152 Crore order book, implying only a 6.2% conversion rate on the quarter. If the 40% annual assumption were real, the company would be tracking to ₹1,261 Crore annualized from that order book alone; clearly, it is not. Project lead times (2–2.5 years typical), government approval delays, and site conditions will determine the real run rate.
The ₹450 Crore Receivables Drag
Underlying Q2's miss is a working-capital crunch management has aired openly: ₹450+ Crore in trade receivables, primarily from government clients in Uttarakhand. These are not disputed — they are due from state governments under water supply and sewage schemes — but they are old. Payment delays have stretched from the typical 2–3 months to 6+ months, citing government payment portal changes (a central policy shift to co-funding models between union and state authorities). The portal was corrected recently, but money has not yet flowed. This receivables drag is not unique to EMS (Indian infrastructure projects routinely face government payment delays), but it is material to this quarter. With ₹450+ Crore stuck in receivables and only ₹193.9 Crore in quarterly revenue, the working-capital cycle is impaired. Profit fell partly because revenue growth slowed, partly because the company is burning cash on non-funded execution. Management expects the payment flow to accelerate in Q3–Q4 FY27, but that is a forecast, not a fait accompli. For a holder, it means near-term cash conversion remains a watch.
What Changed on This Call
Q3–Q4 guidance revised down: from >50% QoQ growth (prior call) to 30–35% QoQ (this call)
Order book upgraded to ₹3,152 Cr total (₹900 Cr added in one quarter)
FY27 target maintained at ₹900–950 Cr (not raised despite order book upgrade)
Receivables forecast: normalization by Q4 FY27 (from government portal reset); timing uncertain
EBITDA margin target held at 25%+ by year-end (vs current 18.5%); PAT margin 25% also restated
The Bull–Bear Ledger
Order book of ₹3,152 Cr provides 2+ years of project visibility at typical execution rates
Sector tailwind: 15-lakh-crore water/sewage opportunity; EMS is ~1% of that market
20-year track record executing government water and sewage projects
Q2 guidance missed by 60%; credibility dented going forward
PAT fell 16.8% YoY despite revenue growth; margin compression, not recovery
₹450+ Cr government receivables stuck 6+ months; material working-capital drag
EBITDA margin target of 25% requires 6.5pp expansion in one half-year; execution risk high
Standalone vs. consolidated divergence (CEO cited ₹160.89 Cr standalone vs ₹193.9 Cr consolidated)
Risks, Ranked by Concern
Government receivables remain stuck into Q3 or later
High₹450+ Cr represents 2.3× Q2 revenue. If collections slip beyond Q4, the company faces a working-capital crisis and potential covenant pressure on any debt.
Q3–Q4 growth misses 30–35% QoQ guidance (again)
HighA second miss would signal execution issues beyond transient receivables delays. Stock would likely re-rate lower, and the order book thesis would be questioned.
EBITDA margin stays below 20% through Q4 (misses 25% target)
MediumMargin compression amid cost inflation would imply the operating leverage narrative is unproven. Profitability recovery would be delayed into FY28.
Order book concentration: 35% in UP, 27% in Rajasthan
MediumIf either state faces budget cuts or payment authority changes, project delays and receivables aging could accelerate.
Project execution delays from monsoon, weather, or government approvals
MediumQ2 saw Uttarakhand monsoon-delayed work. Similar delays in Q3–Q4 would roll revenue forward and push receivables further out.
How the Street Is Positioned
EMS trades at ₹303.85 as of 16 November 2026, down 70.1% from its all-time high of ₹1,016 and trading 18.7% above its 52-week low of ₹256.05. The stock is below its 50-day and 200-day moving averages (SMA50 ₹331.45, SMA200 ₹344.97), signaling a bearish trend. RSI sits at 43.8 (neutral), and volume remains normal — no panic selling, no fresh accumulation. Ownership is thin and illiquid: FII ownership stands at just 0.44%, DII at 0.02%, leaving the promoter (69.70%) in full control. This is an unloved stock in institutional portfolios. Recent bulk/block deals (Sep 2026) show trading activity in the ₹395–₹400 range, with no promoter-linked insider selling near the highs — a neutral signal. The market's verdict, read through price action, is clear: wait and see. The stock has repriced from ₹504 (52-week high) to ₹303.85 on the back of the Q2 miss and guidance cut. That repricing is not irrational — a 60% revenue guidance miss and 17% profit decline warrant a reset. But with volume normal and no distressed selling, the market is not panicking; it is simply deferring to Q3 for proof. If the company executes 30–35% QoQ growth in the next quarter, re-rating will follow.
What to Watch Next
1 · Q3 FY27 QoQ revenue growth (due ~Nov/Dec 2026)
Management guided 30–35% QoQ from Q2 (vs Q1). If Q3 hits ₹252–266 Cr, the company is back on track and Q2 was a stumble. If it misses again, execution is the issue, not receivables. This single data point will reset expectations for FY27 and beyond.
2 · Government receivables clearance (Uttarakhand, UP, others)
The ₹450+ Cr outstanding must start flowing in Q3–Q4. Watch quarterly cash flow statements and trade receivables aging. If receivables stabilize below ₹400 Cr by year-end and working capital cycle improves, the liquidity narrative shifts. If they remain above ₹450 Cr, the working capital burden persists.
3 · EBITDA margin progression (Q3 and Q4 target 25%)
Current EBITDA margin is 18.5%; management targets 25% by FY27 end. Watch Q3 margin. If it moves toward 21–22%, the recovery is real. If it stays flat or compresses further, cost inflation or pricing pressure is too high, and the margin story is broken.
EMS Limited is a structurally sound infrastructure play in a generous sector. But this quarter was not a stumble; it was a miss. Promised 30–35% growth, delivered 12.4%. Promised 50% profit expansion, saw profit fall 17%. The order book is real, the government receivables issue is real, and the margin recovery is an aspiration waiting for proof. The stock is repriced (₹303.85, down 70% from ATH), unloved (FII 0.44%), and waiting. The question for the next quarter is execution: can EMS deliver 30–35% QoQ growth, or is the order book visibility a mirage if receivables and project delays persist? Rating: Hold. The number to track from here is Q3 QoQ revenue growth. Miss it, and re-rate lower. Hit it, and the stock re-rates as a credible water/sewage infrastructure play with 2+ years of visible work. Receivables clearance and margin recovery are the supporting watch points.
Informational and educational content only. Not investment advice.